IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 1.66B
Enterprise value 1.28B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.35
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.05

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 338.71%
S&P500 52-week change 32.54%
52-week high 313.44
52-week low 35.28
50-day moving average 36.52
200-day moving average 37.86

Share statistics

Avg vol (3-month) 34.51M
Avg vol (10-day) 38.27M
Shares outstanding 5224.45M
Implied shares outstanding 6N/A
Float 8178.24M
% held by insiders 10.37%
% held by institutions 189.98%
Shares short (14 May 2023) 423.38M
Short ratio (14 May 2023) 46.01
Short % of float (14 May 2023) 411.47%
Short % of shares outstanding (14 May 2023) 410.42%
Shares short (prior month 13 Apr 2023) 423.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 325 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-34.24%
Return on equity (ttm)-67.55%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -407.74M
Net income avi to common (ttm)-411.66M
Diluted EPS (ttm)-2.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)626.29M
Total cash per share (mrq)2.79
Total debt (mrq)83.23M
Total debt/equity (mrq)12.48
Current ratio (mrq)7.31
Book value per share (mrq)2.97

Cash flow statement

Operating cash flow (ttm)-318.77M
Levered free cash flow (ttm)-175.05M